Skip to content
10-Q

Quarterly Report

EVOFEM BIOSCIENCES, INC. EVFM

0001493152-25-022275

← back to feed
Filed
Nov 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 12, 2025 126.69M sh
Shares Diluted Q3 2025 · Sep 30, 2025 119.58M sh
Shares Diluted Q3 2025 · Sep 30, 2025 116.23M sh
Shares Diluted Q3 2025 · Sep 30, 2024 96.46M sh
Shares Diluted Q3 2025 · Sep 30, 2024 64.92M sh
Capex Q3 2025 · Sep 30, 2025 $2K
Capex Q3 2025 · Sep 30, 2024 $14K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$2.02M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$1.48M
Short Term Debt Q3 2025 · Sep 30, 2025 $291K
Short Term Debt Q3 2025 · Dec 31, 2024 $135K
Stockholders Equity Q3 2025 · Sep 30, 2025 −$75.07M
Stockholders Equity Q3 2025 · Jun 30, 2025 −$69.62M
Stockholders Equity Q3 2025 · Mar 31, 2025 −$69.59M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$71.26M
Stockholders Equity Q3 2025 · Sep 30, 2024 −$70.89M
Stockholders Equity Q3 2025 · Jun 30, 2024 −$69.32M
Stockholders Equity Q3 2025 · Mar 31, 2024 −$70.67M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$66.51M
Current Liabilities Q3 2025 · Sep 30, 2025 $78.19M
Current Liabilities Q3 2025 · Dec 31, 2024 $80.45M
Total Liabilities Q3 2025 · Sep 30, 2025 $83.98M
Total Liabilities Q3 2025 · Dec 31, 2024 $90.26M
Current Assets Q3 2025 · Sep 30, 2025 $7.92M
Current Assets Q3 2025 · Dec 31, 2024 $13.61M
Total Assets Q3 2025 · Sep 30, 2025 $13.81M
Total Assets Q3 2025 · Dec 31, 2024 $23.79M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.01
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.02
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.02
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.09
Eps Basic Q3 2025 · Sep 30, 2025 −$0.01
Eps Basic Q3 2025 · Sep 30, 2025 −$0.02
Eps Basic Q3 2025 · Sep 30, 2024 −$0.02
Eps Basic Q3 2025 · Sep 30, 2024 −$0.09
Sga Expense Q3 2025 · Sep 30, 2025 $2.09M
Sga Expense Q3 2025 · Sep 30, 2025 $6.3M
Sga Expense Q3 2025 · Sep 30, 2024 $3.05M
Sga Expense Q3 2025 · Sep 30, 2024 $8.14M
Net Income Q3 2025 · Sep 30, 2025 −$1.57M
Net Income Q3 2025 · Sep 30, 2025 −$2.4M
Net Income Q3 2025 · Jun 30, 2025 −$1.78M
Net Income Q3 2025 · Mar 31, 2025 $956K
Net Income Q3 2025 · Sep 30, 2024 −$2.37M
Net Income Q3 2025 · Sep 30, 2024 −$5.82M
Net Income Q3 2025 · Jun 30, 2024 $1.35M
Net Income Q3 2025 · Mar 31, 2024 −$4.81M
Operating Income Q3 2025 · Sep 30, 2025 $951K
Operating Income Q3 2025 · Sep 30, 2025 $27K
Operating Income Q3 2025 · Sep 30, 2024 −$2.44M
Operating Income Q3 2025 · Sep 30, 2024 −$6.67M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $905K
Cost Of Revenue Q3 2025 · Sep 30, 2025 $2.03M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $869K
Cost Of Revenue Q3 2025 · Sep 30, 2024 $2.32M
Revenue Q3 2025 · Sep 30, 2025 $4.95M
Revenue Q3 2025 · Sep 30, 2025 $10.62M
Revenue Q3 2025 · Sep 30, 2024 $4.5M
Revenue Q3 2025 · Sep 30, 2024 $12.26M